TABLE 1.
Summary of MRI findings in animals with EAE and in healthy controls.
Animal | FUS performed after immunization (days) | Number of T2w-hyperintense lesions |
Contrast-enhancement |
T2*w signal alteration |
||||||
d9 MRI | d14 MRI | d21 MRI | d9 MRI | d14 MRI | d21 MRI | d9 MRI | d14 MRI | d21 MRI | ||
EAE | ||||||||||
1* | 6 | n/a | 0 | 1 | n/a | 0 | 0 | n/a | 0 | 0 |
2 | 6 | n/a | 0 | 0 | n/a | 0 | 0 | n/a | 0 | 0 |
3 | 6 | n/a | 0 | 0 | n/a | 0 | 0 | n/a | 0 | 0 |
4 | 6 | n/a | n/a | n/a | n/a | 0 | 0 | n/a | 0 | 0 |
5 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6* | 7 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
7 | 7 | 1 | n/a | n/a | 0 | 0 | 0 | 0 | 0 | 0 |
8 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
9* | 9 | n/a | 0 | 2 | n/a | 0 | 0 | n/a | 0 | 0 |
10 | 9 | n/a | 0 | 1 | n/a | 0 | 0 | n/a | 0 | 0 |
11*# | 9 | n/a | 1 | 1 | n/a | 0 | 0 | n/a | 0 | 0 |
12 | 9 | n/a | 1 | 1 | n/a | 0 | 0 | n/a | 0 | 0 |
Control | ||||||||||
1 | n/a | n/a | 0 | n/a | n/a | 0 | n/a | n/a | 0 | n/a |
2 | n/a | n/a | 0 | n/a | n/a | 0 | n/a | n/a | 0 | n/a |
3 | n/a | n/a | 0 | n/a | n/a | 0 | n/a | n/a | 0 | n/a |
4 | n/a | n/a | 0 | n/a | n/a | 0 | n/a | n/a | 0 | n/a |
The asterisks indicate the animals with hyperintense T2w-lesions that could be co-localized to clusters of activated macrophages and microglia. The hashtag indicates the animal with a T2w-lesion that could be co-localized to a cluster of activated Iba1- and TMEM119-positive resident microglia. FUS, focused ultrasound.